• Journal of Acupuncture Research
• /
• 제28권6호
• /
• pp.1-17
• /
• 2011

Objectives : This study aimed to review randomized controlled trials of acupuncture performed in South Korea that used sham acupuncture as a control group. Methods : The following databases were searched through the end of September 2011: Koreanstudies information service system (KISS), Korean medical database (KMbase), national discovery OR science leaders (NDSL), oriental medicine advance searching integrated system (OASIS), and research information service system (RISS). The following search terms were used: acupuncture AND (sham or placebo). The reference lists of searched articles and Korea institute of oriental medicine (KIOM) reports(2005~2009) were identified. The following data were extracted: year/first author, disease, number of participants, blinding, intervention, outcome, and result. Where appropriate, we performed meta-analysis. The methodological quality was assessed according to the Jadad scale and 'risk of bias' by Cochrane Handbook procedure. Results : Twenty-nine studies were included in this review. In eighteen studies, penetrating sham controls were used as the control intervention, whereas the remaining eleven studies adopted non-penetrating sham controls such as the Park Sham Device or blunt auricular acupuncture. Nine studies showed statistically significant difference in outcomes. Twelve studies concerning insomnia after stroke, chronic tension-type headache, idiopathic Parkinson's disease, Hwa-Byung, and smoking cessation were included in meta-analysis. A meta-analysis of insomnia after stroke only found significant difference(MD -4.31, 95% Cl -6.19 to -2.42, $p$<0.00001). In general, all of the studies showed low methodological quality(Jadad score: mean 2.1). Risk of bias by Cochrane Handbook procedure varied. Conclusions : The results of this study could not suggest conclusive evidence that acupuncture is more effective than sham acupuncture in several diseases. In the future, more studies with rigorous acupuncture trials using sham controls should be conducted.

• 지역사회간호학회지
• /
• 제14권2호
• /
• pp.200-210
• /
• 2003

Purpose: This quasi-experimental study was performed to investigate the effects of a health promotion program(HPP) on self-efficacy, healthy lifestyle and blood lipid profile in employees with hyperlipidemia. Methods: The subjects were forty-three employees who were diagnosed as having hyperlipidemia during routine health examination at two worksites in Seoul in 2001. Of the forty-three subjects, thirty were allocated to the experimental group and the remaining thirteen were allocated to the control group. Data were collected from September 24, 2001 to March 16, 2002. The HPP was applied to the experimental group for 11 weeks and included health education, diet counseling, watching videos, conference, and so on. The health education included information about exercise, smoking cessation, and abstinence from drinking alcohol and seven sessions of hyperlipidemia education. The experimental group was requested to keep a daily health promotion lifestyle diary. This diary was analyzed by a dietician and subjects were instructed based on the results. As for data analyses, wilcoxon signed rank test and wilcoxon rank sum test and x2-test were carried out using SAS program. Results: 1. Self-efficacy scores of the experimental group were significantly more increased than those of the control group (experimental: 5.86 10.80, control: -4.04 11.91, p=0.018). 2. Healthy lifestyle scores of the experimental group were significantly more increased than those of the control group (experimental: 0.19 0.26, control: -0.05 0.29, p=0.024). 3. Blood total cholesterol values of the experimental group were significantly more decreased than those of the control group (experimental: -13.07 30.10mg/dl, control: 10.00 26.57mg/dl, p=0.033). 4. Blood triglyceride values of the experimental group were significantly more decreased than those of the control group (experimental: -29.17 192.40mg/dl, control: 63.31 107.53mg/dl, p=0.050). Conclusion: These findings indicate that the HHP could be effective in improving self-efficacy, healthy lifestyle and blood HDL cholesterol and decreasing blood total cholesterol in employees with hyperlipidemia. Therefore, the HHP could be suggested as an effective nursing intervention for employees in the worksite by ultimately preventing cerebral and cardiac vessel complications related to hyperlipidemia.

• Journal of Yeungnam Medical Science
• /
• 제25권1호
• /
• pp.19-30
• /
• 2008

골다공증은 골밀도와 골의 질로 구성되는 골의 강도가 손상됨으로 골절의 위험이 높아지는 골격질환이며, 최근 유병율이 점차 증가하고 있는 추세이다. 임상적으로 무증상인 경우가 많으며 방사선학적 검사인 단순 방사선 검사, 골 스캔, CT, MRI 등이 골밀도 및 골절의 진단에 유용하다. 골밀도의 정량적 검사로는 이중에너지 방사선 흡수법, 정량적 전산화 단층촬영이 사용되고 있다. 골다공증의 진단은 WHO 기준에 따라 T-score가 -2.5 이하일 경우 진단할 수 있다. 그 외에 생화학적 골표지자들도 진단에 도움이 된다. 골다공증 치료제는 골흡수억제제와 골형성자극제(formation stimulator)로 나눌 수 있는데 골흡수억제제로는 칼슘, 에스트로겐, 칼시토닌, 비스포스포네이트(bisphosphonate), 비타민 D 등이 있으며 골량을 증가시키는 골형성자극제로는 현재 부갑상선 호르몬이 유일하며 최근 strontium ranelate가 추가되었다. 일일 1200 mg의 칼슘과 800 IU 의 비타민 D 섭취가 권장되고 있으며, 폐경기 여성에서 에스트로겐이 효과가 입증되었고 골다공증으로 인한 통증에는 칼시토닌이 효과가 있다. 비스포스포네이트는 폐경 후 골다공증의 치료, 예방 및 스테로이드에 의한 골다공증 치료에 대해 FDA의 승인을 받았다. 폐경 후 골다공증의 치료, 예방에 사용되는 SERM은 골의 질을 향상시킴으로써 골절을 예방한다고 알려져 있다. 골형성자극제인 부갑상선 호르몬이 골절의 위험을 감소시킨다고 보고된 바 있으며, strontium은 최근에 개발된 약제로 3상 연구에서 골절 위험율 감소효과를 보였으나 더 많은 연구가 필요할 것으로 생각된다.